Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Valeant Says No Agreement Reached on $327 Million Hostile Offer for Ista
Bloomberg
Friday, January 6, 2012 - 12:48pm
tags:
Valeant Pharmaceuticals, hostile bid, Ista, M&A
Shire says UK will lead EU review on Venvanse
Reuters
Friday, January 6, 2012 - 11:51am
tags:
Shire, UK, Venvanse, ADHD
J&J Halts Study of Doribax Antibiotic on Higher Death Rate
Bloomberg
Friday, January 6, 2012 - 11:50am
tags:
JNJ, Doribax, antibiotics
Pfizer’s Share of Lipitor Market Will Continue to Fall, Watson CEO Says
Bloomberg
Friday, January 6, 2012 - 11:49am
tags:
Watson, generics, Pfizer, Lipitor, Paul Bisaro, Pharma CEOs
Parents sue Pfizer over birth defects allegedly caused by Zoloft
Madison Country Record, IL
Friday, January 6, 2012 - 11:47am
tags:
Pfizer, Zoloft, birth defects
Two Short-Term Risks For Johnson & Johnson
Seeking Alpha
Friday, January 6, 2012 - 11:42am
tags:
JNJ, Abbott Laboratories, Bristol-Myers Squibb, Pfizer, Novartis
J&J Said to Agree to Pay $1 Billion in Risperdal Marketing Probe
Bloomberg
Friday, January 6, 2012 - 10:02am
tags:
JNJ, Risperdal, settlements, off-label, antipsychotics
BioDelivery Sciences rallies 133% to $1.96 after signing deal with Endo
Yahoo/Fly on the Wall
Friday, January 6, 2012 - 10:00am
tags:
Endo, BioDelivery Sciences
Couple says defective recalled Children's Tylenol killed 2-year-old son; J&J disputes that
Yahoo/AP
Friday, January 6, 2012 - 9:59am
tags:
JNJ, recalls, Tylenol
Targacept: Alzheimer's drug studies will continue
Yahoo/AP
Thursday, January 5, 2012 - 1:56pm
tags:
Targacept, Alzheimer's disease, AZD1446, AstraZeneca
XOMA to eliminate 34% of personnel, take one-time charges of $6M
Yahoo/Fly on the Wall
Thursday, January 5, 2012 - 1:11pm
tags:
Xoma, layoffs, reorganization
InterMune's Esbriet rings up $2.8 million in sales since mid-September launch in Germany
Yahoo/AP
Thursday, January 5, 2012 - 1:01pm
tags:
Esbriet, InterMune, IPF, idiopathic pulmonary fibrosis, Germany
Dendreon Surges After Fourth-Quarter Product Revenue Triples
Bloomberg Businessweek
Thursday, January 5, 2012 - 12:45pm
tags:
Dendreon, earnings, Provenge
Will Amgen Buy Out Biogen Idec?
Seeking Alpha
Thursday, January 5, 2012 - 12:39pm
tags:
Biogen Idec, Amgen, M&A
Galena Biopharma announces FDA approves IND application
Yahoo/Fly on the Wall
Thursday, January 5, 2012 - 12:38pm
tags:
Galena Biopharma, FDA, NeuVax, Herceptin, Roche
Buy Celgene As Markets, Revenues, And Earnings Expand
Seeking Alpha
Thursday, January 5, 2012 - 12:35pm
tags:
Celgene
Let Pfizer Compete in the Generic Market with Lipitor
Pharmareform
Thursday, January 5, 2012 - 12:34pm
tags:
generics, Pfizer, Lipitor
Drug Approvals Hit a Seven-Year High in 2011 on Improved Data
Bloomberg
Thursday, January 5, 2012 - 12:27pm
tags:
drug approvals
Merck CEO: This year will be better than 2011
Yahoo/AP
Thursday, January 5, 2012 - 12:26pm
tags:
Merck, Kenneth Frazier, Pharma CEOs
Ista Pharma expects greater income, sales in 2012
Yahoo/AP
Thursday, January 5, 2012 - 12:25pm
tags:
Ista, guidance

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.